These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27519355)

  • 1. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS; Abu-Much A; Maini AS; Zhou Z; Li Y; Batchelor WB; Grines CL; Baron SJ; Redfors B; Lansky AJ; Basir MB; O'Neill WW
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013503. PubMed ID: 38708609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function.
    Stähli BE; Gebhard C; Gick M; Ferenc M; Mashayekhi K; Buettner HJ; Neumann FJ; Toma A
    Clin Res Cardiol; 2018 Mar; 107(3):259-267. PubMed ID: 29134346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease.
    Kinoshita T; Asai T; Suzuki T
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):315-21.e3. PubMed ID: 26142149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
    Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
    Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
    Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of future hemodialysis risk and beneficial outcomes for patients with chronic kidney disease undergoing recanalization of chronic total occlusion.
    Shimura T; Yamamoto M; Tsuchikane E; Teramoto T; Kimura M; Matsuo H; Kawase Y; Suzuki Y; Kano S; Habara M; Nasu K; Kinoshita Y; Terashima M; Matsubara T; Suzuki T
    Int J Cardiol; 2016 Nov; 222():707-713. PubMed ID: 27521544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Renal Transplant Recipients Undergoing Percutaneous Coronary Intervention.
    Zheng WC; Evans N; Dinh D; Bloom JE; Brennan AL; Ball J; Lefkovits J; Shaw JA; Reid CM; Chan W; Stub D
    Heart Lung Circ; 2024 Jul; 33(7):998-1008. PubMed ID: 38565437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
    Chang TI; Leong TK; Kazi DS; Lee HS; Hlatky MA; Go AS
    Am Heart J; 2013 May; 165(5):800-8, 808.e1-2. PubMed ID: 23622918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.
    Parsh J; Seth M; Aronow H; Dixon S; Heung M; Mehran R; Gurm HS
    J Am Coll Cardiol; 2015 Jun; 65(25):2714-23. PubMed ID: 26112195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study.
    Vuurmans T; Er L; Sirker A; Djurdjev O; Simkus G; Levin A
    Coron Artery Dis; 2018 Jan; 29(1):8-16. PubMed ID: 28938241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
    Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
    Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.
    Tajti P; Karatasakis A; Danek BA; Alaswad K; Karmpaliotis D; Jaffer FA; Choi JW; Yeh RW; Patel M; Mahmud E; Burke MN; Krestyaninov O; Khelimskii D; Toma C; Doing AH; Uretsky B; Koutouzis M; Tsiafoutis I; Wyman RM; Garcia S; Holper E; Xenogiannis I; Rangan BV; Banerjee S; Ungi I; Brilakis ES
    J Invasive Cardiol; 2018 Nov; 30(11):E113-E121. PubMed ID: 30218557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.